Addressing the Opiate Safety Crisis in Vulnerable Veterans

Injectable extended-release formulation of naltrexone marketed as Vivitrol is a recent significant addition to substance use disorder pharmacotherapy for alcohol and for opiate dependence. It is especially helpful due to the lack of abuse potential and for its ability to block the effects of other opioids. Additionally, Vivitrol is an effective alternative for patients with low rates of adherence to oral medications.

Injectable extended-release formulation of naltrexone marketed as Vivitrol is a recent significant addition to substance use disorder pharmacotherapy for alcohol and for opiate dependence. It is especially helpful due to the lack of abuse potential and for its ability to block the effects of other opioids. Additionally, Vivitrol is an effective alternative for patients with low rates of adherence to oral medications.

Related Resources

Advocacy Webinar Recording
Public
All AHA webinars are free of charge but require advance registration. AHA does not offer continuing education credits for its webinars. They are always 60…
Case Studies
Public
After recognizing asthma as a major condition for many patients in the emergency department, St. Luke's Cornwall Hospital partnered with Hudson Valley Asthma…
Advocacy Webinar Recording
Public
Increasingly, hospitals and health systems are forming partnerships to attain the new and demanding capabilities required to manage population health under…
Case Studies
Public
The Community Health Network (CHN) targets the socioeconomic determinants of health that are not typically addressed in a health care system. The program…
Case Studies
Public
Demand for Brockton Neighborhood Health Center (BNHC) accelerated after it started in 1994 as a mobile medical van in a church parking lot. BNHC is a nonprofit…
Case Studies
Public
Codman Square Health Center in downtown Dorchester, MA exemplifies how a health center can build and advocate for a healthy community. Established in 1979 by…